Drug intelligence / Profile preview

allium sativum ethyl acetate extract

Development stage
Preclinical
Lead developer
University of Tunis El Manar
Modality
Small Molecules
01

Overview

Allium sativum ethyl acetate extract (EAEAS) is a specialized phytochemical preparation derived from garlic, currently under investigation for its potential as an adjuvant therapy in acute myeloid leukemia (AML). Research indicates that EAEAS exerts potent cytotoxic effects on AML blasts by inducing the intrinsic apoptotic pathway. This mechanism involves mitochondrial membrane depolarization, DNA fragmentation, and the activation of executioner caspases 3 and 7. Furthermore, preliminary evidence suggests that the extract may possess selective activity against leukemia stem cell (LSC) subpopulations, which are often resistant to conventional chemotherapy and responsible for disease relapse. Developed primarily in academic research settings, such as the University of Tunis El Manar, EAEAS represents a natural product-based approach to enhancing treatment outcomes in hematological malignancies.

Other names
garlic ethyl acetate extractAllium sativum L. ethyl acetate extract
02

Targets

CASP7 (Caspase-7)CASP3 (Caspase-3)

Beyond the preview

Go deeper on allium sativum ethyl acetate extract.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on allium sativum ethyl acetate extract.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call